Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemiaKlaudyna Fidyt, Małgorzata Firczuk, Wojciech Fendler et al.|Molecular Oncology|2019Cited by 37
PF161 THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVOKlaudyna Fidyt, Małgorzata Firczuk, Agata Pastorczak et al.|HemaSphere|2019Cited by 0